Aminosalicylates: potential antineoplastic actions in colon cancer prevention.
Allgayer
Hubert
H
Oncology Dept., Reha-Klinik Ob der Tauber der LVA Baden-Württemberg, Germany. allgayer@reha-klinik-odt.de
Kruis
Wolfgang
W
D000236:Adenoma / Q000517:prevention & control; D000636:Aminosalicylic Acids / Q000627:therapeutic use*; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003110:Colonic Neoplasms / Q000517:prevention & control*; D015179:Colorectal Neoplasms / Q000517:prevention & control; D004249:DNA Damage; D006801:Humans; D011451:Prostaglandin-Endoperoxide Synthases / Q000502:physiology; D051381:Rats
D000636:Aminosalicylic Acids; D000894:Anti-Inflammatory Agents, Non-Steroidal; D011451:Prostaglandin-Endoperoxide Synthases